Secret Powder Fresh Antiperspirant Spray Recalled for Benzene Contamination
The Procter & Gamble Company is recalling Secret antiperspirant/deodorant spray due to the presence of benzene, a chemical contaminant. The recall affects multiple lot numbers distributed nationwide and internationally.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This recall is classified as FDA Class I, which requires a minimum severity rating of Severe. No illnesses or injuries are reported in the source material, but benzene is a known chemical hazard that warrants this serious classification.
Plain-English summary
The Procter & Gamble Company has recalled Secret Powder Fresh Antiperspirant/Deodorant topical spray due to the presence of benzene, a chemical contaminant. The recall applies to multiple lot numbers available in 4 oz, 6 oz, and twin-pack formats. The affected product was distributed nationwide in the United States and Puerto Rico, as well as internationally to Canada, Guam, and numerous other territories.
The FDA classified this as a Class I recall in response to the benzene contamination. Specific lot numbers with expiration dates ranging from January 2022 through August 2023 are subject to the recall.
Consumers who have purchased Secret Powder Fresh Antiperspirant/Deodorant spray should verify their product against the list of recalled lot numbers available from the FDA. If your product bears a recalled lot number, you should discontinue use immediately.
The recalled product
- Product
- Secret, powder fresh, Aluminum chlorohydrate 24%, Anti-Perspirant/Deodorant, Topical spray can Net Wt., (a) 4OZ (113g), NDC 37000-134-11, UPC 0 37000 71109 4, (b) 6OZ (170g), NDC 37000-134-17, UPC 0 37000 71108 7; (c) twin pack-2 each can Net Wt. 6OZ (170g), NDC: 37000-134-01,
- Manufacturer
- The Procter & Gamble Company
- Category
- Drug — Antiperspirant/Deodorant
- Hazard
- benzene
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot #: (a &b) 00701458SJ
- 00861458SA
- 00871458SA
- Exp 1/28/2022
- 00921458SK
- Exp 3/31/2022
- 01701458SJ
- 01711458SE
- Exp 5/31/2022
- 03431458SA
- 03441458SA
- 03531458SM
- Exp 11/30/2022
- 10681458SJ
- 10691458SA
- 10701458SA
- 10781458SE
- 10811458SJ
- Exp 2/28/2023
- 11701458SH
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27
- SevereErythromycin Tablets Recalled for Impurity Above Acceptable Limits
FDA (Drugs) · 2026-05-27